The regulation of artificial intelligence (AI) has become a hot topic in recent years, especially as AI systems like ChatGPT continue to grow in prominence. OpenAI’s CEO, Sam Altman, recently testified before the Senate Judiciary Committee, emphasizing the need for collaboration…
Source: www.kevinmd.com – Read more
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
